In MS patients, excess NEAT1 leads to re-localization of SFPQ (splicing factor proline/glutamine-rich) from the IL-8 promoter, resulting in transcriptional activation of IL-8 (Imamura et al., 2014). The gene discussed is CXCL8; the disease is myeloid sarcoma.